225 related articles for article (PubMed ID: 26005016)
21. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
[TBL] [Abstract][Full Text] [Related]
22. Detection and significance of serum protein markers of small-cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
[TBL] [Abstract][Full Text] [Related]
23. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
24. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
[TBL] [Abstract][Full Text] [Related]
25. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
[TBL] [Abstract][Full Text] [Related]
26. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
27. Discovery and identification of Serum Amyloid A protein elevated in lung cancer serum.
Dai S; Wang X; Liu L; Liu J; Wu S; Huang L; Xiao X; He D
Sci China C Life Sci; 2007 Jun; 50(3):305-11. PubMed ID: 17609886
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
31. Analyzing the percentage of different PD-1
Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
[TBL] [Abstract][Full Text] [Related]
32. Is there any potential clinical impact of serum phosphorus and magnesium in patients with lung cancer at first diagnosis? A multi-institutional study.
Kouloulias V; Tolia M; Tsoukalas N; Papaloucas C; Pistevou-Gombaki K; Zygogianni A; Mystakidou K; Kouvaris J; Papaloucas M; Psyrri A; Kyrgias G; Gennimata V; Leventakos K; Panayiotides I; Liakouli Z; Kelekis N; Papaloucas A
Asian Pac J Cancer Prev; 2015; 16(1):77-81. PubMed ID: 25640394
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.
Ren Y; Hou J; Xu A; Pan Y
Int J Clin Exp Pathol; 2015; 8(11):14709-16. PubMed ID: 26823795
[TBL] [Abstract][Full Text] [Related]
36. [Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].
Li ZG; Zhao L; Liu L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):48-52. PubMed ID: 17374239
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.
Zhao W; Yu H; Han Z; Gao N; Xue J; Wang Y
Int J Clin Exp Pathol; 2015; 8(8):9506-11. PubMed ID: 26464712
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
Molina R; Augé JM; Bosch X; Escudero JM; Viñolas N; Marrades R; Ramírez J; Carcereny E; Filella X
Tumour Biol; 2009; 30(3):121-9. PubMed ID: 19506400
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
[TBL] [Abstract][Full Text] [Related]
40. Serum protein profiles of patients with lung cancer of different histological types.
Yang RH; Tian RF; Ren QL; Chui HY; Guo ST; Zhang XD; Song X
Asia Pac J Clin Oncol; 2016 Mar; 12(1):70-6. PubMed ID: 26668125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]